VGVeronika Golovina

Veronika Golovina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Veronika Golovina has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Availability of the Great Saphenous Veins as Conduits for Arterial Bypass Surgery in Patients with Varicose Veins

    byΒ Veronika Golovina, Vladislav Panfilov, Evgenii Seliverstov, Darina Erechkanova, Igor Zolotukhin

    Background: The great saphenous vein (GSV) has long been recognized as the best conduit for vascular bypass procedures. Concomitant varicose veins disease may be a reason for GSV unavailability either due to dilatation and tortuosity of the vein or due to its destruction during invasive venous treatment. Objectivesβ€”to assess the rate of varicose vein patients with concomitant lower extremity arterial disease (LEAD) who have previously lost their GSV due to venous ablation. Material and Methods: A total of 285 patients (76 F, 209 M) with LEAD were consecutively enrolled. A total of 111 patients (222 limbs) underwent a detailed duplex ultrasound of the lower extremity veins for assessing suitability of the GSV as a conduit. We registered presence of varicose veins (VVs), type of previous invasive procedure and availability of saphenous veins as possible grafts. Results: The mean age of screened patients was 70.5 Β± 9.1.62 (21.75%) patients had varicose veins or were operated on before due to varicose veins. A total of 42 patients with varicose veins had C2 disease, 10 had C3, 9 had C4 and 1 had C6 according to CEAP classification. A total of 222 lower extremities were examined by duplex ultrasound of which 51 limbs had VVs. Despite the presence of varicose tributaries, the GSV was suitable for bypass in 9 of those lower extremities. The GSV was not available as a conduit in 34 (19.9%) ipsilateral lower extremities in the LEAD with no VVs group and in 42 (82.6%) ipsilateral lower extremities in the LEAD with VVs group (p = 0.0001). Varicose vein disease was associated with a higher frequency of the GSV unavailability (odds ratio 18.8, 95% confidence interval 8.35–42.35). On the 11 ipsilateral limbs (5% of LEAD patients and 21.6% of LEAD with VVs patients), the GSV was unavailable due to previous venous interventions. Conclusions: Almost 20% of patients may have both LEAD and VVs. Among those with VVs, most have the ipsilateral GSV unavailable as a potential conduit. Additionally, one fifth of limbs with VVs had GSVs destroyed previously due to saphenous ablative procedures.


  • Open Access

    Availability of the Great Saphenous Veins as Conduits for Arterial Bypass Surgery in Patients with Varicose Veins

    byΒ Veronika Golovina, Vladislav Panfilov, Evgenii Seliverstov, Darina Erechkanova, Igor Zolotukhin

    Background The great saphenous vein (GSV) has long been recognized as a best conduit for vascular bypass procedures. Concomitant varicose veins disease may be a reason for GSV unavailability either due to dilatation and tortuosity of the vein or due to its destruction during invasive venous treatment. Aim - to assess the rate of varicose vein patients with concomitant lower extremity arterial disease (LEAD) who have previously lost their GSV due to venous ablation. Material and methods 285 patients (76 F, 209 M) with LEAD were consecutively enrolled. Demographic data and medical history were taken. Physical examination and duplex ultrasound were performed. We registered presence of varicose veins (VVs), type of previous invasive procedure and availability of saphenous veins as possible grafts. Results Mean age of screened LEAD patients was 70.5Β±9.1. 62 (21.75%) patients had varicose veins or were operated on before due to varicose veins. 42 patients with varicose veins had C2 disease, 10 had C3, nine had C4 and one had C6 according to CEAP classification. Duplex ultrasound examination of the veins of the lower extremities was performed on 111 patients (222 lower extremities). The total number of lower extremities without ipsilateral GSV was 76 (34.2%) due to varicosity, small size, previous ablation or postthrombotic intraluminal changes. 53 limbs in 32 patients had VVs. Despite the presence of varicose tributaries, the GSV was suitable for bypass in 9 lower extremities. GSV was not available as a conduit in 34 (20.1%) ipsilateral lower extremities in the LEAD group and in 42 (79.3%) ipsilateral lower extremities in the LEAD with VVs group (p= 0.0001). Varicose vein disease was associated with a higher frequency of the GSV unavailability odds ratio 18.8 (95% confidence interval 8.35 – 42.35). On the 11 ipsilateral limbs (5%) GSV was unavailable due to previous venous interventions. Conclusions Almost 20% of patients may have both LEAD and VVs. Among those with VVs, most have the ipsilateral GSV unavailable as a potential conduit. Additionally, one fifth of limbs with VVs had GSVs destroyed previously due to saphenous ablative procedures.


  • Treatment and Secondary Prevention of Venous Thromboembolic Events in Fragile Patients in a Real-life Practice

    byΒ V.I. Golovina, O.I. Efremova, I.A. Zolotukhin

    ΠŸΡ€Π΅Π΄ΡΡ‚Π°Π²Π»Π΅Π½ ΠΎΠ±Π·ΠΎΡ€ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹, посвящСнный ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΠ°ΠΌ использования прямых ΠΎΡ€Π°Π»ΡŒΠ½Ρ‹Ρ… антикоагулянтов (ПОАК) ΠΏΡ€ΠΈ Π»Π΅Ρ‡Π΅Π½ΠΈΠΈ Π²Π΅Π½ΠΎΠ·Π½Ρ‹Ρ… тромбоэмболичСских ослоТнСний (Π’Π’Π­Πž) Ρƒ Β«Ρ…Ρ€ΡƒΠΏΠΊΠΈΡ…Β» ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², ΠΊ ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΌ относятся Π»ΠΈΡ†Π° старчСского возраста (β‰₯75 Π»Π΅Ρ‚) ΠΈ/ΠΈΠ»ΠΈ с Π½ΠΈΠ·ΠΊΠΎΠΉ массой Ρ‚Π΅Π»Π° (≀50 ΠΊΠ³), ΠΈ/ΠΈΠ»ΠΈ с Π½Π°Ρ€ΡƒΡˆΠ΅Π½Π½ΠΎΠΉ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠ΅ΠΉ ΠΏΠΎΡ‡Π΅ΠΊ (БКЀ ≀50 ΠΌΠ»/ΠΌΠΈΠ½). АнализируСтся ряд исслСдований, основанных Π½Π° Π΄Π°Π½Π½Ρ‹Ρ… ΠΈΠ· рСгистров RIETE, XALIA, PREFER-VTE ΠΈ ДрСздСнского рСгистра, Π° Ρ‚Π°ΠΊΠΆΠ΅ Π΄Ρ€ΡƒΠ³ΠΈΡ… исслСдований, Ρ€Π°ΡΡΠΌΠ°Ρ‚Ρ€ΠΈΠ²Π°ΡŽΡ‰ΠΈΡ… Π°Π½Ρ‚ΠΈΠΊΠΎΠ°Π³ΡƒΠ»ΡΠ½Ρ‚Π½ΡƒΡŽ Ρ‚Π΅Ρ€Π°ΠΏΠΈΡŽ Ρƒ этой ΠΊΠ°Ρ‚Π΅Π³ΠΎΡ€ΠΈΠΈ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ². Π‘Π΄Π΅Π»Π°Π½Ρ‹ Π²Ρ‹Π²ΠΎΠ΄Ρ‹, Ρ‡Ρ‚ΠΎ Π² Π³Ρ€ΡƒΠΏΠΏΠ΅ Β«Ρ…Ρ€ΡƒΠΏΠΊΠΈΡ…Β» ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², ΠΏΡ€ΠΈΠ½ΠΈΠΌΠ°ΡŽΡ‰ΠΈΡ… Π°Π½Ρ‚ΠΈΠΊΠΎΠ°Π³ΡƒΠ»ΡΠ½Ρ‚Π½ΡƒΡŽ Ρ‚Π΅Ρ€Π°ΠΏΠΈΡŽ ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρƒ Π’Π’Π­Πž, Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ риск гСморрагичСских ослоТнСний Π² сравнСнии с риском ΠΏΠΎΠ²Ρ‚ΠΎΡ€Π½ΠΎΠ³ΠΎ Π’Π’Π­Πž. Помимо этого, ΡΡ€Π°Π²Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΉ Π°Π½Π°Π»ΠΈΠ· ПОАК со стандартной антикоагулянтной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠ΅ΠΉ ΠΏΠΎΠΊΠ°Π·Π°Π» ряд прСимущСств Π² Π²ΠΈΠ΄Π΅ сниТСния частоты развития большого кровотСчСния ΠΈ риска Ρ€Π΅Ρ†ΠΈΠ΄ΠΈΠ²Π° Π’Π’Π­Πž. ΠŸΡ€Π΅Π΄ΡΡ‚Π°Π²Π»Π΅Π½Π½Ρ‹Π΅ Π΄Π°Π½Π½Ρ‹Π΅ ΠΌΠΎΠ³ΡƒΡ‚ Π±Ρ‹Ρ‚ΡŒ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Π½Ρ‹ Π² качСствС ΠΏΠΎΠΌΠΎΡ‰ΠΈ ΠΏΡ€ΠΈ Π²Ρ‹Π±ΠΎΡ€Π΅ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Ρ€Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ ΠΌΠ΅Ρ‚ΠΎΠ΄Π° лСчСния Π’Π’Π­Πž Ρƒ Β«Ρ…Ρ€ΡƒΠΏΠΊΠΈΡ…Β» ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ².


  • Cytokines in Pathogenesis of Varicose Veins

    byΒ V.I. Golovina, E.I. Seliverstov, O.I. Efremova, I.A. Zolotukhin

    ΠŸΠ°Ρ‚ΠΎΠ³Π΅Π½Π΅Π· Π²Π°Ρ€ΠΈΠΊΠΎΠ·Π½ΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ Π΄ΠΎ сих ΠΏΠΎΡ€ остаСтся Π΄ΠΎ ΠΊΠΎΠ½Ρ†Π° Π½Π΅ ΠΈΠ·ΡƒΡ‡Π΅Π½Π½Ρ‹ΠΌ ΠΈ слуТит ΠΏΡ€Π΅Π΄ΠΌΠ΅Ρ‚ΠΎΠΌ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ исслСдования клиницистов ΠΈ ΡƒΡ‡Π΅Π½Ρ‹Ρ… Ρ„ΡƒΠ½Π΄Π°ΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½Ρ‹Ρ… Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½ΠΈΠΉ ΠΌΠ΅Π΄ΠΈΡ†ΠΈΠ½Ρ‹. ΠŸΡ€ΠΈΡ‡ΠΈΠ½ΠΎΠΉ ΡƒΠ·Π»ΠΎΠ²Π°Ρ‚ΠΎΠΉ трансформации ΠΏΡ€ΠΈΠ·Π½Π°ΡŽΡ‚ Ρ€Π΅ΠΌΠΎΠ΄Π΅Π»ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ Π²Π΅Π½ΠΎΠ·Π½ΠΎΠΉ стСнки, ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ΅, Π² свою ΠΎΡ‡Π΅Ρ€Π΅Π΄ΡŒ, развиваСтся Π² Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π΅ Ρ‚Π°ΠΊ Π½Π°Π·Ρ‹Π²Π°Π΅ΠΌΠΎΠ³ΠΎ вСноспСцифичСского воспалСния. Π­Ρ‚ΠΎΡ‚ хроничСский процСсс Π²ΠΊΠ»ΡŽΡ‡Π°Π΅Ρ‚ комплСкс взаимодСйствий ΠΌΠ΅ΠΆΠ΄Ρƒ ΠΊΠ»Π΅Ρ‚ΠΊΠ°ΠΌΠΈ, ΠΎΡ‚Π²Π΅Ρ‡Π°ΡŽΡ‰ΠΈΠΌΠΈ Π·Π° Π²ΠΎΡΠΏΠ°Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΡƒΡŽ Ρ€Π΅Π°ΠΊΡ†ΠΈΡŽ (Π½Π΅ΠΉΡ‚Ρ€ΠΎΡ„ΠΈΠ»Ρ‹, Π»ΠΈΠΌΡ„ΠΎΡ†ΠΈΡ‚Ρ‹, ΠΌΠΎΠ½ΠΎΡ†ΠΈΡ‚Ρ‹, ΠΌΠ°ΠΊΡ€ΠΎΡ„Π°Π³ΠΈ), ΡΠ½Π΄ΠΎΡ‚Π΅Π»ΠΈΠ°Π»ΡŒΠ½Ρ‹ΠΌΠΈ ΠΊΠ»Π΅Ρ‚ΠΊΠ°ΠΌΠΈ, Π³Π»Π°Π΄ΠΊΠΎΠΌΡ‹ΡˆΠ΅Ρ‡Π½Ρ‹ΠΌΠΈ ΠΊΠ»Π΅Ρ‚ΠΊΠ°ΠΌΠΈ сосудов ΠΈ Π²Π½Π΅ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½Ρ‹ΠΌ матриксом. ΠšΡ€ΠΎΠΌΠ΅ Ρ‚ΠΎΠ³ΠΎ, вСноспСцифичСскоС воспалСниС ΠΏΡ€ΠΎΡ‚Π΅ΠΊΠ°Π΅Ρ‚ ΠΏΡ€ΠΈ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠΌ участии Ρ†ΠΈΡ‚ΠΎΠΊΠΈΠ½ΠΎΠ², ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ ΠΏΡ€Π΅Π΄ΡΡ‚Π°Π²Π»ΡΡŽΡ‚ собой Ρ€Π°Π·Π½ΠΎΠΎΠ±Ρ€Π°Π·Π½ΡƒΡŽ Π³Ρ€ΡƒΠΏΠΏΡƒ Π½Π΅Π±ΠΎΠ»ΡŒΡˆΠΈΡ… Π±Π΅Π»ΠΊΠΎΠ², ΠΏΡ€ΠΎΠ΄ΡƒΡ†ΠΈΡ€ΡƒΠ΅ΠΌΡ‹Ρ… Ρ€Π°Π·Π½Ρ‹ΠΌΠΈ ΠΈΠΌΠΌΡƒΠ½Π½Ρ‹ΠΌΠΈ ΠΈ сосудистыми ΠΊΠ»Π΅Ρ‚ΠΊΠ°ΠΌΠΈ, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅, дСйствуя Π² пикомолярных ΠΈ наномолярных концСнтрациях, Π°ΠΊΡ‚ΠΈΠ²ΠΈΡ€ΡƒΡŽΡ‚ спСцифичСскиС Ρ€Π΅Ρ†Π΅ΠΏΡ‚ΠΎΡ€Ρ‹ ΠΈ ΠΌΠΎΠ΄ΡƒΠ»ΠΈΡ€ΡƒΡŽΡ‚ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΈ ΠΌΠ½ΠΎΠ³ΠΈΡ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ ΠΈ Ρ‚ΠΊΠ°Π½Π΅ΠΉ. Роль Ρ†ΠΈΡ‚ΠΎΠΊΠΈΠ½ΠΎΠ² Π² ΠΏΠ°Ρ‚ΠΎΠ³Π΅Π½Π΅Π·Π΅ Π²Π°Ρ€ΠΈΠΊΠΎΠ·Π½ΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ остаСтся ΠΌΠ°Π»ΠΎΠΈΠ·ΡƒΡ‡Π΅Π½Π½ΠΎΠΉ Π²Π²ΠΈΠ΄Ρƒ слоТности изучСния ΠΈΡ… ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΠ° дСйствия. ΠŸΡ€Π΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π΅Ρ‚ΡΡ, Ρ‡Ρ‚ΠΎ ΠΈΡ… Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ опосрСдуСт Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ рСгулирования Π΄Π΅Π³Ρ€Π°Π΄Π°Ρ†ΠΈΠΈ Π²Π½Π΅ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠ³ΠΎ матрикса, Π²ΠΈΠ΄ΠΎΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΠΎΡΡ‚Π°Π²Π»ΡΡŽΡ‰ΠΈΡ… Π²Π½Π΅ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠ³ΠΎ матрикса, Ρ‚Π°ΠΊΠΈΡ… ΠΊΠ°ΠΊ ΠΊΠΎΠ»Π»Π°Π³Π΅Π½ ΠΈ эластин, сниТСниС количСства Π³Π»Π°Π΄ΠΊΠΎΠΌΡ‹ΡˆΠ΅Ρ‡Π½Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ, Ρ‡Ρ‚ΠΎ ΠΏΡ€ΠΈΠ²ΠΎΠ΄ΠΈΡ‚ ΠΊ сниТСнию эффСктивности сокращСния сосудистой стСнки ΠΈΠ·-Π·Π° Ρ„Ρ€Π°Π³ΠΌΠ΅Π½Ρ‚Π°Ρ†ΠΈΠΈ ΠΌΡ‹ΡˆΠ΅Ρ‡Π½ΠΎΠ³ΠΎ слоя Π²Π΅Π½Ρ‹. Π¦ΠΈΡ‚ΠΎΠΊΠΈΠ½Ρ‹ ΡƒΡ‡Π°ΡΡ‚Π²ΡƒΡŽΡ‚ ΠΈ Π² процСссах Π°ΠΊΡ‚ΠΈΠ²Π°Ρ†ΠΈΠΈ Π»Π΅ΠΉΠΊΠΎΡ†ΠΈΡ‚ΠΎΠ², Ρ‡Ρ‚ΠΎ ΠΏΡ€ΠΈΠ²ΠΎΠ΄ΠΈΡ‚ ΠΊ Π²Ρ‹ΡΠ²ΠΎΠ±ΠΎΠΆΠ΄Π΅Π½ΠΈΡŽ свободных Ρ€Π°Π΄ΠΈΠΊΠ°Π»ΠΎΠ², Π°ΠΊΡ‚ΠΈΠ²Π°Ρ†ΠΈΠΈ ΠΏΡ€ΠΎΡ‚Π΅Π°Π·Ρ‹ ΠΈ ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π΅ΠΉ Π΄Π΅Π³Ρ€Π°Π΄Π°Ρ†ΠΈΠΈ Π³Π»Π°Π΄ΠΊΠΎΠΌΡ‹ΡˆΠ΅Ρ‡Π½Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ. Π’ Ρ€Π°ΠΌΠΊΠ°Ρ… Π΄Π°Π½Π½ΠΎΠΉ Ρ€Π°Π±ΠΎΡ‚Ρ‹ прСдставлСна общая информация ΠΎ Ρ†ΠΈΡ‚ΠΎΠΊΠΈΠ½Π°Ρ…, Π° Ρ‚Π°ΠΊΠΆΠ΅ ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· исслСдований, Π² ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… ΠΈΠ·ΡƒΡ‡Π΅Π½ΠΎ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠ΅ влияниС Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… ΠΌΠΎΠ»Π΅ΠΊΡƒΠ» Π½Π° Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎΠ³ΠΎ Π²Π°Ρ€ΠΈΠΊΠΎΠ·Π½ΠΎΠ³ΠΎ Ρ€Π°ΡΡˆΠΈΡ€Π΅Π½ΠΈΡ Π²Π΅Π½.